Congenital self-healing reticulohistiocytosis

From WikiMD's WELLNESSPEDIA


Congenital self-healing reticulohistiocytosis
Synonyms Hashimoto-Pritzker disease
Pronounce N/A
Specialty N/A
Symptoms Skin lesions
Complications N/A
Onset Neonatal
Duration Self-healing
Types N/A
Causes Unknown
Risks None known
Diagnosis Clinical diagnosis, Skin biopsy
Differential diagnosis Langerhans cell histiocytosis, Infection, Malignancy
Prevention N/A
Treatment None required
Medication N/A
Prognosis Excellent
Frequency Rare
Deaths N/A


Congenital self-healing reticulohistiocytosis (also known as Hashimoto-Pritzker disease) is a rare, benign skin condition. It is characterized by skin lesions that appear at birth or in early infancy and spontaneously regress over a period of weeks to months.

Symptoms[edit]

The primary symptom of congenital self-healing reticulohistiocytosis is the presence of skin lesions. These lesions are typically red or purple in color and may be found anywhere on the body. They may be solitary or multiple, and they may vary in size. The lesions are not typically associated with any other symptoms, and they spontaneously regress without treatment.

Causes[edit]

The exact cause of congenital self-healing reticulohistiocytosis is unknown. It is thought to be a disorder of the immune system, specifically the histiocytes, which are a type of white blood cell. Some researchers believe that it may be related to an abnormal response to infection or injury.

Diagnosis[edit]

Diagnosis of congenital self-healing reticulohistiocytosis is typically made based on the characteristic appearance of the skin lesions. A skin biopsy may be performed to confirm the diagnosis. The biopsy will show an infiltration of histiocytes in the skin.

Treatment[edit]

As the name suggests, congenital self-healing reticulohistiocytosis typically resolves on its own without treatment. However, in some cases, treatment may be needed to manage symptoms or to speed up the healing process. Treatment options may include topical corticosteroids or other anti-inflammatory medications.

Prognosis[edit]

The prognosis for individuals with congenital self-healing reticulohistiocytosis is generally good. The skin lesions typically resolve on their own within a few weeks to months, and there are usually no long-term complications. However, in rare cases, the disease may recur.

See also[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.